Also for weight loss, GoodRx currently offers prefilled pens of semaglutide, sold as Ozempic and Wegovy, for $199 for the first 2 fills of 0.25-mg and 0.50-mg doses—in addition to the $39 per month fee for unlimited online care—and Zepbound (tirzepatide; Eli Lilly) at $299 for the first fill of a 2.5-mg vial and syringe. 5

BofA analyst Allen Lutz lowered the firm’s price target on GoodRx (GDRX) to $2.60 from $3 and keeps an Underperform rating on the shares. Heading

Pharmacy benefit manager MedImpact is teaming up with GoodRx on a new program that offers drug discounts "seamlessly" at the pharmacy counter. Under the initiative, when a MedImpact member gets a prescription filled, the cost under the benefit will ...

GoodRx (GDRX) downgraded due to falling users and policy risks. Learn about new revenue sources and competitive threats.

In today’s Pharma Pulse, GoodRx slashes cash prices for the new Wegovy pill, a federal judge halts the 340B rebate pilot, and Sanofi doubles down on Earendil Labs’ AI platform for autoimmune breakthroughs.

Digital healthcare platform GoodRx taps former GoDaddy top exec Scott Wagner to serve as interim CEO as co-founders Doug Hirsch and Trevor Bezdek step down from the top leadership position. Hirsch and Bezdek transitioned into new roles as chief mission ...